InChI=1S/C45H54N8O10/c1-6-31-42(59)52-22-11-14-32(52)43(60)51(5)34(24-27-16-18-29(19-17-27)50(3)4)44(61)53-23-20-30(54)25-33(53)39(56)49-37(28-12-8-7-9-13-28)45(62)63-26(2)36(40(57)47-31)48-41(58)38-35(55)15-10-21-46-38/h7-10,12-13,15-19,21,26,31-34,36-37,55H,6,11,14,20,22-25H2,1-5H3,(H,47,57)(H,48,58)(H,49,56)/t26-,31-,32+,33+,34+,36+,37+/m1/s1 |
YGXCETJZBDTKRY-DZCVGBHJSA-N |
CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccc(cc2)N(C)C)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 |
|
Streptomyces pristinaespiralis
(NCBI:txid38300)
|
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
|
|
View more via ChEBI Ontology
N-[(6R,9S,10R,13S,15aS,22S,24aS)-22-{[4-(dimethylamino)phenyl]methyl}-6-ethyl-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyldocosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide
|
4-[4-(Dimethylamino)-N-methyl-L-phenylalanine]virginiamycin S1
|
KEGG COMPOUND
|
Antibiotic PA 114B
|
KNApSAcK
|
Antibiotic PA 114B1
|
KNApSAcK
|
Mikamycin B
|
KEGG COMPOUND
|
Mikamycin B
|
KNApSAcK
|
NSC 92554
|
KNApSAcK
|
Ostreogrycin B
|
ChemIDplus
|
Pristinamycin IA
|
KEGG COMPOUND
|
Streptogramin B
|
KEGG COMPOUND
|
Vernamycin B alpha
|
KEGG COMPOUND
|
3131-03-1
|
CAS Registry Number
|
ChemIDplus
|
78387
|
Reaxys Registry Number
|
Reaxys
|
|